Metformin: are potential benefits on cancer risk extended to cancer survival?
- PMID: 24258614
- PMCID: PMC3868416
- DOI: 10.1634/theoncologist.2013-0381
Metformin: are potential benefits on cancer risk extended to cancer survival?
Conflict of interest statement
Disclosures of potential conflicts of interest may be found at the end of this article.
Comment on
-
Metformin is associated with survival benefit in cancer patients with concurrent type 2 diabetes: a systematic review and meta-analysis.Oncologist. 2013;18(12):1248-55. doi: 10.1634/theoncologist.2013-0111. Epub 2013 Nov 20. Oncologist. 2013. PMID: 24258613 Free PMC article.
References
-
- Bosetti C, Rosato V, Polesel J, et al. Diabetes mellitus and cancer risk in a network of case-control studies. Nutr Cancer. 2012;64:643–651. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
